Abstract
This review discusses the therapeutic potential of brain-derived neurotrophic factor (BDNF) for retinal degeneration. BDNF, nerve growth factor (NGF), neurotrophin 3 (NT-3) and NT-4/NT-5 belong to the neurotrophin family. These neuronal modulators activate a common receptor and a specific tropomyosin-related kinase (Trk) receptor. BDNF was identified as a photoreceptor protectant in models of retinal degeneration as early as 1992. However, development of effective therapeutics that exploit this pathway has been difficult due to challenges in sustaining therapeutic levels in the retina.
Author supplied keywords
Cite
CITATION STYLE
Daly, C., Ward, R., Reynolds, A. L., Galvin, O., Collery, R. F., & Kennedy, B. N. (2018). Brain-derived neurotrophic factor as a treatment option for retinal degeneration. In Advances in Experimental Medicine and Biology (Vol. 1074, pp. 465–471). Springer New York LLC. https://doi.org/10.1007/978-3-319-75402-4_57
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
